A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027)
Clinical trial NCT03449134 · COMPLETED
Trial details
- NCT number
- NCT03449134
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-14
- Primary completion
- 2020-06-05
- Enrollment
- 732
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.